Rieu M, Reznik Y, Vannetzel J M, Mahoudeau J, Berrod J L, Kuhn J M
Department of Endocrinology, Saint Michel Hospital, Paris, France.
J Clin Endocrinol Metab. 1995 Aug;80(8):2404-9. doi: 10.1210/jcem.80.8.7629236.
There are few critical studies on plasma testosterone (T) and 17 beta-estradiol (E2) levels in men with hCG-producing tumors, and the results are contradictory. Plasma E2 levels are most often elevated, whereas plasma T values are high or in the normal range. We studied the plasma levels of such steroids and of delta 4 and delta 5 T precursors in adult men with intact hCG-producing tumors to evaluate the relationship between hCG and steroid hormone levels or steroidogenic enzyme activities. Ten adult men with hCG-producing tumors and 25 normal adult men were investigated. Seven men with testicular tumors were studied before and after hemicastration. The 2 patients with extratesticular tumors were investigated before and during chemotherapy. The remaining patient was studied every 2 months for 1 yr during the spontaneous course of the disease. Plasma progesterone (P), 17 alpha-hydroxyprogesterone (17-OHP), androstenedione (A), 17-hydroxy-delta 5-pregnenolone (17-OH delta 5-P), dehydroepiandrosterone (DHEA), T, E2, and hCG were measured, and ratios of steroid levels were also calculated. In patients with increased hCG values (i.e. > 5 IU/L), the mean plasma P, 17-OHP, A, 17-OH delta 5-P, DHEA, T, and E2 levels were higher (P < 0.01 at least) than those in patients whose hCG values were normalized or in controls. The patterns of these steroids were very different according to plasma hCG levels. Indeed, for hCG levels between more than 5 and 3.5 x 10(3) IU/L, positive correlations (P < 0.05 at least) were found between hCG levels and delta 4 T precursor, delta 5 T precursor, T, or E2 values. Conversely, for hCG values greater than 3.5 x 10(3) IU/L, hCG levels were negatively correlated (P < 0.05 at least) to all steroid values. Furthermore, in patients with increased hCG levels, the mean plasma P to 17-OHP ratio, 17-OHP to A ratio, A to T ratio, 17-OHP to T ratio, and 17-OH delta 5-P to DHEA ratio were similar to those in patients with normalized hCG values or in controls. In contrast, in patients with increased hCG levels, the mean plasma T to E2 ratio value was lower (P < 0.001) than that in patients with normalized hCG levels or in controls.(ABSTRACT TRUNCATED AT 400 WORDS)
关于产生人绒毛膜促性腺激素(hCG)肿瘤男性患者的血浆睾酮(T)和17β-雌二醇(E2)水平,目前的关键性研究较少,且结果相互矛盾。血浆E2水平大多升高,而血浆T值则偏高或处于正常范围。我们研究了成年男性体内具有完整产生hCG肿瘤的此类类固醇以及Δ4和Δ5 T前体的血浆水平,以评估hCG与类固醇激素水平或类固醇生成酶活性之间的关系。对10名患有产生hCG肿瘤的成年男性和25名正常成年男性进行了调查。对7名患有睾丸肿瘤的男性在半侧睾丸切除前后进行了研究。对2名患有睾丸外肿瘤的患者在化疗前及化疗期间进行了调查。对其余1名患者在疾病自然病程中每2个月进行1年的研究。测定了血浆孕酮(P)、17α-羟孕酮(17-OHP)、雄烯二酮(A)、17-羟基-Δ5-孕烯醇酮(17-OHΔ5-P)、脱氢表雄酮(DHEA)、T、E2和hCG,并计算了类固醇水平的比值。在hCG值升高(即>5 IU/L)的患者中,血浆P、17-OHP、A、17-OHΔ5-P、DHEA、T和E2的平均水平(至少P<0.01)高于hCG值恢复正常的患者或对照组。根据血浆hCG水平,这些类固醇的模式差异很大。实际上,对于hCG水平在5至3.5×10³IU/L之间的情况,发现hCG水平与Δ4 T前体、Δ5 T前体、T或E2值之间存在正相关(至少P<0.05)。相反,对于hCG值大于3.5×10³IU/L的情况,hCG水平与所有类固醇值呈负相关(至少P<0.05)。此外,在hCG水平升高的患者中,血浆P与17-OHP的比值、17-OHP与A的比值、A与T的比值、17-OHP与T的比值以及17-OHΔ5-P与DHEA的比值与hCG值恢复正常的患者或对照组相似。相比之下,在hCG水平升高的患者中,血浆T与E2的平均比值低于hCG水平恢复正常的患者或对照组(P<0.001)。(摘要截取自400字)